Canada Life
ALXO icon

Canada Life’s ALX Oncology ALXO Stock Holding History

Canada Life’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,379
Closed -$14K – 2071
2024
Q2 		$14K Hold
2,379
– – ﹤0.01% 2072
2024
Q1 		$27K Buy
+2,379
New +$33.4K ﹤0.01% 2061
2023
Q2 		– Sell
-496
Closed -$2K – 2261
2023
Q1 		$2K Hold
496
– – ﹤0.01% 2312
2022
Q4 		$6K Hold
496
– – ﹤0.01% 2340
2022
Q3 		$5K Hold
496
– – ﹤0.01% 2379
2022
Q2 		$4K Hold
496
– – ﹤0.01% 2418
2022
Q1 		$9K Hold
496
– – ﹤0.01% 2439
2021
Q4 		$11K Hold
496
– – ﹤0.01% 2435
2021
Q3 		$37K Hold
496
– – ﹤0.01% 2305
2021
Q2 		$27K Hold
496
– – ﹤0.01% 2423
2021
Q1 		$36K Hold
496
– – ﹤0.01% 2393
2020
Q4 		$43K Buy
+496
New +$29.8K ﹤0.01% 2333

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's ALXO Position: Q3 2024 in Review

Canada Life sold out of ALX Oncology (ALXO) in Q3 2024, closing a stake of 2,379 shares — an estimated $14K sold.

Canada Life first reported a position in ALXO in Q4 2020 and held it in 12 quarters. The position peaked at $43K in Q4 2020. 92 funds tracked by Wall St. Rank hold ALXO as of Q3 2024.

  • Canada Life reported no remaining ALX Oncology position as of Q3 2024 after selling out during the quarter.
  • Canada Life sold 2,379 ALX Oncology shares in Q3 2024, an estimated $14K.
  • Canada Life first reported a position in ALX Oncology in Q4 2020 and held it in 12 quarters.
  • Canada Life's ALX Oncology position peaked at $43K in Q4 2020.
  • 92 funds tracked by Wall St. Rank held ALX Oncology as of Q3 2024.

Based on Canada Life's 13F filing for Q3 2024, filed 13 Nov 2024.